MX2022010592A - Formulaciones y usos de las mismas. - Google Patents

Formulaciones y usos de las mismas.

Info

Publication number
MX2022010592A
MX2022010592A MX2022010592A MX2022010592A MX2022010592A MX 2022010592 A MX2022010592 A MX 2022010592A MX 2022010592 A MX2022010592 A MX 2022010592A MX 2022010592 A MX2022010592 A MX 2022010592A MX 2022010592 A MX2022010592 A MX 2022010592A
Authority
MX
Mexico
Prior art keywords
formulations
preparations
exosome
organelle
crossing
Prior art date
Application number
MX2022010592A
Other languages
English (en)
Inventor
Joyce H Ma
Original Assignee
Joyce H Ma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joyce H Ma filed Critical Joyce H Ma
Publication of MX2022010592A publication Critical patent/MX2022010592A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describen preparaciones y formulaciones capaces de atravesar e incorporarse a una membrana de una célula o un orgánulo o un exosoma. También se describen métodos de tratamientos que utilizan las preparaciones y formulaciones.
MX2022010592A 2020-02-28 2021-02-26 Formulaciones y usos de las mismas. MX2022010592A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062982918P 2020-02-28 2020-02-28
PCT/US2021/019821 WO2021173933A1 (en) 2020-02-28 2021-02-26 Formulations and uses thereof

Publications (1)

Publication Number Publication Date
MX2022010592A true MX2022010592A (es) 2023-01-11

Family

ID=77463244

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010592A MX2022010592A (es) 2020-02-28 2021-02-26 Formulaciones y usos de las mismas.

Country Status (16)

Country Link
US (4) US11801302B2 (es)
EP (1) EP4110066A4 (es)
JP (1) JP2023516616A (es)
KR (1) KR20220148853A (es)
CN (1) CN115605092A (es)
AU (1) AU2021227936A1 (es)
BR (1) BR112022016789A2 (es)
CA (1) CA3169327A1 (es)
CL (1) CL2022002312A1 (es)
CO (1) CO2022012819A2 (es)
IL (1) IL295102B2 (es)
MX (1) MX2022010592A (es)
MY (1) MY209097A (es)
PH (1) PH12022552082A1 (es)
WO (1) WO2021173933A1 (es)
ZA (1) ZA202208636B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL295102B2 (en) * 2020-02-28 2026-04-01 Joyce H Ma Formulations and their uses
WO2022123434A1 (en) * 2020-12-07 2022-06-16 Mohan Dewan A therapeutic oil composition and a process for its preparation
CN116637107B (zh) * 2022-02-15 2025-06-10 四川大学 一种负载天然抗氧化剂的抗肿瘤纳米药物及其负载比例筛选方法
US12571108B2 (en) * 2022-03-12 2026-03-10 Razor Keep, LLC Blade preserving products and methods for manufacturing
CN115531256B (zh) * 2022-10-12 2023-08-04 植物医生(广东)生物科技有限公司 一种精华油及其制备工艺
CN115989812A (zh) * 2022-12-12 2023-04-21 云南中医药大学 一种增强孜然挥发油抑菌活性剂的制备方法
US20240398689A1 (en) * 2023-05-31 2024-12-05 Aih Personal Care Pro, Llc Argan Oil Blend Hair Treatment
DE102023120215A1 (de) 2023-07-28 2025-01-30 RRNO-Research GmbH Mischung aus sekundären Pflanzenstoffen und deren Wirkung auf den alternden Organismus
IT202300023415A1 (it) * 2023-11-07 2025-05-07 Dario Fedele Formulazione per applicazione topica comprendente una matrice idrofoba a base di olio extravergine di oliva, e almeno un principio attivo idrofilo disperso nella matrice idrofoba
TR2024000493A2 (tr) * 2024-01-16 2025-07-21 Anadolu Ueniversitesi Strateji Gelistirme Daire Baskanligi Enkapsüle edilmiş nioli uçucu yağı içeren serum.
CN117919315A (zh) * 2024-01-26 2024-04-26 成都市第三人民医院 一种花椒外泌体在制备防治炎症性肠病药物中的应用
CN118178582B (zh) * 2024-04-10 2024-09-17 广东广药健康产业有限公司 一种穴位按摩复方止痛精油及其制备方法
CN118614519B (zh) * 2024-05-23 2025-03-25 江门君汉科技有限公司 一种驱蚊组合物、用途及空间驱避微胶囊

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146638A (en) 1996-12-10 2000-11-14 Wakunaga Pharmaceutical Co., Ltd. Fermented garlic composition
GB9704904D0 (en) 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
WO2001070289A2 (en) 2000-03-20 2001-09-27 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
IT1317890B1 (it) * 2000-08-03 2003-07-15 Idi Irccs Preparato da utilizzare come componente lipidico nei cosmetici.
IT1317911B1 (it) 2000-09-28 2003-07-15 Idi Irccs Formulazione cosmetica.
US6528040B1 (en) 2001-01-18 2003-03-04 Maurine Pearson EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
FR2831442B1 (fr) * 2001-10-30 2005-02-11 Oreal Composition cosmetique mimant le sebum, et utilisations
US20040185115A1 (en) 2002-05-17 2004-09-23 Maurine Pearson Emu oil based methods and compositions for skin ailments
US7029711B2 (en) * 2003-12-09 2006-04-18 Shannon Lynn Farrell Mixture of and method of making a trancutaneous pain relief composition
JPWO2006004106A1 (ja) 2004-07-05 2008-04-24 マルキンバイオ株式会社 ザクロ果汁、ザクロ果汁粉末及び該粉末の製造方法
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006105306A2 (en) * 2005-03-29 2006-10-05 Arizona Chemical Company Compostions containing fatty acids and/or derivatives thereof and a low temperature stabilizer
US20080311613A1 (en) * 2007-06-14 2008-12-18 The Government Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Services Artificial skin surface film liquids
MY145791A (en) 2009-05-25 2012-04-30 Liang Woon San A method for producing a nutraceutical composition and the nutraceutical produced by the method
US8765106B2 (en) * 2009-10-26 2014-07-01 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
US8343468B2 (en) * 2009-10-26 2013-01-01 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US8268364B1 (en) * 2010-02-19 2012-09-18 Mintiva Holdings LLC Water based pain relieving composition
US20120328549A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Oil compositions
SG183579A1 (en) * 2011-02-11 2012-09-27 Agency Science Tech & Res Methods of detecting therapeutic exosomes
US9138446B2 (en) 2011-06-08 2015-09-22 Scott Alan Weisenfluh EMU oil in combination with other active ingredients for treating skin imperfections
WO2013003459A2 (en) * 2011-06-30 2013-01-03 Elc Management Llc Transfer resistant cosmetic composition
CN102628002A (zh) * 2012-03-31 2012-08-08 华健 一种青刺果油脂的制备工艺
WO2013158318A1 (en) 2012-04-16 2013-10-24 Zemtsov Enterprises, Llc Formulations and methods for treatment of acne and inflammatory skin conditions
FR2991871B1 (fr) * 2012-06-15 2014-07-25 Oreal Procede pour matifier la peau grasse
WO2014039423A1 (en) * 2012-09-05 2014-03-13 International Flora Technologies, Ltd. Human sebum mimetics derived from botanical sources and methods for making the same
WO2014078234A1 (en) 2012-11-13 2014-05-22 Agrigenetics, Inc. Shelf life of food flavors and essential oil mixes by using high oleic sunflower oil as the carrier oil
CN103536473A (zh) * 2013-10-17 2014-01-29 苏州威尔德工贸有限公司 一种保湿柔肤水
US20170360073A1 (en) * 2014-11-07 2017-12-21 Jolly Mathew Vadakkemuri Optimized nutrient fatty acid composition
WO2016090150A1 (en) * 2014-12-03 2016-06-09 Mary Kay Inc. Cosmetic composition and methods of use thereof
CN104651087A (zh) * 2015-02-09 2015-05-27 福建美力生生物科技股份有限公司 一种亚麻油手工皂
AU2017254777A1 (en) * 2016-04-21 2018-12-06 Sang Pacific Enterprises Pty Ltd Method of treating inflammation and promoting wound healing
CN108379126A (zh) * 2018-04-26 2018-08-10 广东岭南职业技术学院 一种鸸鹋油护肤膏及其制作方法
AU2019291885A1 (en) * 2018-06-27 2021-02-04 CoLabs International Corporation Compositions comprising silicon dioxide-based particles including one or more agents
CN109846757B (zh) * 2019-02-15 2022-01-11 广州环亚化妆品科技有限公司 一种皮脂仿生组合物及包含其的化妆品
IL295102B2 (en) * 2020-02-28 2026-04-01 Joyce H Ma Formulations and their uses

Also Published As

Publication number Publication date
US12414993B2 (en) 2025-09-16
EP4110066A4 (en) 2024-04-17
BR112022016789A2 (pt) 2022-10-11
AU2021227936A1 (en) 2022-09-01
CA3169327A1 (en) 2021-09-02
CL2022002312A1 (es) 2023-04-21
CO2022012819A2 (es) 2022-09-20
IL295102A (en) 2022-09-01
US11801302B2 (en) 2023-10-31
IL295102B1 (en) 2025-12-01
PH12022552082A1 (en) 2024-02-12
CN115605092A (zh) 2023-01-13
US20210268110A1 (en) 2021-09-02
KR20220148853A (ko) 2022-11-07
US11801303B2 (en) 2023-10-31
EP4110066A1 (en) 2023-01-04
JP2023516616A (ja) 2023-04-20
WO2021173933A1 (en) 2021-09-02
US20250387485A1 (en) 2025-12-25
US20230000987A1 (en) 2023-01-05
MY209097A (en) 2025-06-21
US20230405126A1 (en) 2023-12-21
ZA202208636B (en) 2023-11-29
IL295102B2 (en) 2026-04-01

Similar Documents

Publication Publication Date Title
ZA202208636B (en) Formulations and uses thereof
WO2020236972A3 (en) Non-classi engineered crispr-cas polynucleotide targeting system
MX2021002415A (es) Celulas madre hematopoyeticas modificadas geneticamente y usos de las mismas.
EP3908369A4 (en) COMPACT PROTON THERAPY SYSTEMS AND METHODS
WO2020172492A3 (en) Bacterial membrane preparations
EP4241769A3 (en) Bisphosphocin gel formulations and uses thereof
MX2021007479A (es) Polipeptidos multimericos moduladores de linfocitos t y metodos de uso de estos.
CU20210041A7 (es) Péptidos inmunogénicos con motivos de oxidorreductasa
BR112023016056A2 (pt) Válvulas e conjuntos de elevação de gás elétricos
AU201815816S (en) Inhaler
EP4222176A4 (en) POLYPEPTIDE CONJUGATES AND METHODS OF USE
WO2022245977A3 (en) Methods for the expansion of human granulocytemacrophage progenitors and applications thereof
EP4333166A4 (en) BATTERY HOUSING AND BATTERY
ZA202307404B (en) Anti-met antibodies and uses thereof
EP4120958A4 (en) IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF
MX2022011077A (es) Variantes de transglutaminasa.
ZA202210638B (en) Applications of pi4k inhibitor in intracellular protein misfolding-related diseases and lysosomal storage diseases
EP4228603A4 (en) CELL MEMBRANE VESICLES AND USES THEREOF
WO2023102091A3 (en) Microbial consortia
ZA202100854B (en) Personal care compositions
EP4168028A4 (en) IMMUNDOMINANT SARS-COV-2 PEPTIDES AND USES THEREOF
WO2022221479A3 (en) Magec2 immunogenic peptides, binding proteins recognizing magec2 immunogenic peptides, and uses thereof
WO2021076755A8 (en) An activity-guided map of electrophile-cysteine interactions in primary human immune cells
WO2019028422A9 (en) METHODS OF ACTIVATION OF IMMUNE CELLS
EP4144323A4 (en) DENTAL MEMBRANE AND COMPREHENSIVE DENTAL MEMBRANE APPROACH